Bioactive Dehydrotyrosyl and Dehydrodopyl Compounds of Marine Origin by Sugumaran, Manickam & Robinson, William E.
Mar. Drugs 2010, 8, 2906-2935; doi:10.3390/md8122906 
 
Marine Drugs  
ISSN 1660-3397 
www.mdpi.com/journal/marinedrugs 
Review 
Bioactive Dehydrotyrosyl and Dehydrodopyl Compounds of 
Marine Origin  
Manickam Sugumaran 
1,* and William E. Robinson 
2  
1  Department of Biology, University of Massachusetts Boston, Boston, MA 02125, USA 
2  Environmental, Earth and Ocean Sciences Department, University of Massachusetts Boston, 
Boston, MA 02125, USA; E-Mail: william.robinson@umb.edu  
*  Author to whom correspondence should be addressed; E-Mail: manickam.sugumaran@umb.edu; 
Tel.: +1-617-287-6598; Fax: +1-617-287-6650.  
Received: 19 October 2010; in revised form: 26 November 2010 / Accepted: 1 December 2010 /  
Published: 6 December 2010 
 
Abstract: The amino acid, tyrosine, and its hydroxylated product, 3,4-dihydroxyphenylalanine 
(dopa), plays an important role in the biogenesis of a number of potentially important 
bioactive  molecules  in  marine  organisms.  Interestingly,  several  of  these  tyrosyl  and 
dopa-containing compounds possess dehydro groups in their side chains. Examples span 
the  range  from  simple  dehydrotyrosine  and  dehydrodopamines  to  complex  metabolic 
products,  including  peptides  and  polycyclic  alkaloids.  Based  on  structural  information, 
these compounds can be subdivided into five categories: (a) Simple dehydrotyrosine and 
dehydrotyramine containing molecules; (b) simple dehydrodopa derivatives; (c) peptidyl 
dehydrotyrosine  and  dehydrodopa  derivatives;  (d)  multiple  dehydrodopa  containing 
compounds;  and  (e)  polycyclic  condensed  dehydrodopa  derivatives.  These  molecules 
possess a wide range of biological activities that include (but are not limited to) antitumor 
activity, antibiotic activity, cytotoxicity, antioxidant activity, multidrug resistance reversal, 
cell division inhibition, immunomodulatory activity, HIV-integrase inhibition, anti-viral, 
and  anti-feeding  (or  feeding  deterrent)  activity.  This  review  summarizes  the  structure, 
distribution, possible biosynthetic origin, and biological activity, of the five categories of 
dehydrotyrosine and dehydrodopa containing compounds.  
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1. Introduction 
The origin of almost all antibiotics used today can be traced back to naturally occurring compounds 
isolated  from  bacteria  and  fungi.  While  the  majority  of  our  current  antibiotics  are  considered 
―semisynthetic‖ (i.e., modified versions of natural products that are synthetically mass produced), there 
is only a limited number of totally man-made antibiotic compounds that have proven to be effective in 
combating  bacterial  pathogens,  such  as  the  broad-spectrum  quinolones  and  sulfonamides,  and  the 
Gram-positive targeted oxazolidinones [1]. Because of this, the search for new antibiotics still relies 
initially on the identification of natural products. Moreover, development of bacterial resistance to a 
large number of the currently prescribed antibiotics, particularly multi-drug resistance (MDR), has 
caused serious concern among health care professionals [2,3]. Many experts agree that the lack of 
development of new antibiotics to replace the ones that are currently ineffective is currently a major 
threat to human health, and in the years to come. Therefore, there is an urgent need to develop new 
antibiotics,  especially  for  controlling  MDR  bacteria  that  are  often  found  in  hospitals  and  nursing 
homes located in high population density areas. More broadly, there is also a pressing need for new 
anti-fungal, anti-viral and anti-tumor compounds.  
Marine  organisms  seem  to  be  a  particularly  likely  source  of  new  antimicrobial  and  antitumor 
compounds. Although over 70% of the Earth’s surface is covered by oceans, only about 15% of the 
approximately  1.8  to  2.0  million  species  that  have  currently  been  named,  live  in  the  marine 
environment [4]. In contrast, biodiversity appears to be far greater in the oceans than on land, since the 
oceans currently support 32 phyla, whereas only 12 phyla are present on land [4]. Marine waters are 
therefore a potentially rich source of undiscovered natural products. Marine metabolites and other 
natural  products  have to  work in  saline environments,  thus,  to  some extent, pre-adapting them  to 
human physiological conditions. Nevertheless, their aqueous environment causes rapid dilution, which 
could greatly reduce their effectiveness. To avoid such dilution problems, many aquatic organisms 
have evolved efficient and more potent metabolites that exhibit higher toxicity/biological activity even 
at extremely low concentrations. Hence, marine metabolites could potentially work in physiological 
saline at concentrations much below the levels needed by compounds of terrestrial origin. 
Within the marine environment, marine invertebrates should prove to be a rich source of bioactive 
compounds.  Over  95%  of  all  animals  are  invertebrates,  with  over  33  invertebrate  phyla  [5]. 
Nevertheless, over 90% of the marine invertebrate species are yet to be described [5]. We would argue 
that  the  diversity  of  invertebrate  community  structure,  organism-to-organism  interactions,  intricate 
food  webs  (predator-prey  as  well  as  competition),  broad  range  of  reproductive  strategies,  and 
host-parasite relationships would make invertebrates a potentially rich source of bioactive compounds. 
Lacking the complicated immune system of higher animals, marine invertebrates successfully manage 
to evade and fight infection using a plethora of host defense mechanisms including the use of antibiotic 
peptides. With such advantages, it is clear that marine invertebrate compounds deserve more attention 
in the development of newer and more effective antibiotics and other important bioactive compounds.  
However, a large-scale, animal collection, tissue homogenization and activity-screening approach to 
examining possible bioactive compounds in invertebrates is a poor strategy, and is unlikely to be 
repeatedly  successful.  René   Dubos,  credited  with  the  discovery  of  the  first  naturally  occurring 
antibiotic gramicidin, was also the first to advocate for a deliberate, systematic approach for searching Mar. Drugs 2010, 8  
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for antibacterial compounds [6]. The conventional ways to find new antibiotic compounds, although 
more systematic than the ―shotgun‖ approach, rely on screening techniques employing libraries of both 
synthetic and naturally occurring compounds. Yet such screening techniques have not generated the 
much-needed  arsenal  of  chemicals  to  combat  different  disease-causing  bacteria.  We  advocate  a 
different systematic strategy—use known structural data on specific groups of bioactive compounds 
that have been isolated from marine invertebrates to identify likely antibiotics, and then use chemical 
modification and synthesis to enhance antibiotic potency. Unfortunately, current knowledge of groups 
of bioactive compounds is patchy and incomplete, thereby limiting the number of systematic studies 
that can be sustained. 
One  particularly  rich  group  of  bioactive  compounds  is  the  dopa/topa-containing  compounds  in 
marine invertebrates (and more specifically, dehydrotyrosyl/dopa compounds). Even a cursory glance 
at the literature of compounds possessing dehydrotyrosyl/dopyl units reveals that these compounds are 
widely and uniquely distributed in marine invertebrates, possess unusual biological properties, and 
often exhibit antibiotic activities. Such compounds have been found in a very diverse (and apparently 
unrelated)  number  of  phyla,  including  the  Porifera  (sponges),  Cnidaria  (coelenterates),  Mollusca 
(bivalves), Arthropoda (insects) and Urochordata (ascidians). This latter group is of particular interest 
to us. Ascidians (also called tunicates or simply sea squirts; subphylum Tunicata, Class Ascidiacea) are 
sessile marine filter-feeding invertebrates that exhibit features in their free-swimming larval stage that 
are  characteristic  of  the  vertebrates,  including  gill  slits,  notocord  and  dorsal  nerve  cord,  yet  are 
considered to be a highly divergent offshoot from the other members of the Chordata [7]. As we will 
discuss  later,  a  number  of  species  of  tunicates  contain  various,  low  molecular  weight,  dopa-  or 
topa-containing peptides (or modified peptides) in their blood cells or other body tissues including styelins 
from Styela clava [8], plicatamide from Styela plicata [9], halocyamines from Halocynthia roretzi [10], 
lamellarins  from  Didemnum  chartaceum  [11],  ferreascidin  from  Pyura stolonifera  [12]  and 
tunichromes from eleven species of tunicates [13–19]. Although there is a wealth of information on 
invertebrate bioactive compounds, to date these data have been stumbled upon (a stochastic process) 
rather than systematically investigated (a scientific process). Our aim is to review what is known about 
this group of compounds, highlight chemical relationships within the group, and suggest promising 
avenues for future research. This is the first step in the approach we advocate to systematically search 
for new dehydrotyrosyl/dopyl compounds in marine species to add to the existing list of potentially 
new antibiotic compounds to tackle the multiple drug-resistance problem. Adding the structures of 
newly discovered dehydrotyrosyl/dopyl compounds to the list of currently known compounds will 
better enable researchers to then address the structure-activity relationships.  
Dopa- and topa-containing compounds often possess dehydro groups in their side chains. Examples 
span the range from simple dehydrotyrosine and dehydrodopamines to complex metabolic products, 
including  peptides  and  polycyclic  alkaloids.  Structural  information  allows  these  compounds  to  be 
divided into five categories: (a) simple dehydrotyrosine- and dehydrotyramine-containing compounds; 
(b) simple dehydrodopa derivatives; (c) simple peptidyl dehydrotyrosine and dehydrodopa derivatives; 
(d)  multiple  dehydrodopa-containing  compounds;  and  (e)  polycyclic  condensed  dehydrodopa 
derivatives. We will address each of these in turn.  Mar. Drugs 2010, 8  
 
 
2909 
2.  Simple  Dehydrotyrosine  Derivatives:  Tuberine,  Erbastatin,  p-Hydroxycinnamaldehyde, 
Lasoidine,  Botryllamide,  Hamigeramine,  Hamigeroxalamic  Acid,  Tridentatols,  Anthosamines, 
Cyclo-Arg-Dehydrotyrosine and Rigidins  
The first dehydrotyrosine derivative that was shown to possess biological activity was tuberine [20]. 
Tuberine  (1)  possessed  mild  antibiotic  properties.  The  related  erbstatin  (2)  was  isolated  by 
Umezawa et al. [21] (Figure 1) from the culture broth of Streptomyces amnkusaensis. These authors 
demonstrated its potential to inhibit tyrosine-specific protein kinase activity. Leem et al. [22] identified 
p-hydroxy cinnamaldehyde (3) as an antibacterial substance from the saw fly, Acantholyda parki. The 
tetrapeptide lasoidine A, (4) isolated by Marchand et al. in 1969 [23] from an African buckthorn plant 
(family  Rhamnaceae),  contains  a  dehydrotyrosine  residue.  However,  the  first  group  of  marine 
compounds  possessing  dehydrotyrosine  unit  is  botryllamides  [24].  They  were  isolated  from  two 
species of ascidians, Botryllus sp. from Philippines and Botryllus schlosseri from the Great Barrier 
Reef of Australia. They showed mild cytotoxicity against the human colon cancer cell line HCT-116. 
Henrich  et  al.  [25]  used  a  different  species  of  Botryllus  (B.  tyreus)  and  isolated  a  number  of 
botryllamides  (5–14)  all  possessing  dehydrotyramine  units  (Figure  2).  These  compounds  are 
apparently  derived  from  a  tyrosyl  tyrosine  dipeptide  by  modification.  Botryllamides  proved  to  be 
effective inhibitors of the ATP binding cassette (ABC) transporter called ABCG2 that is associated 
with multi drug resistance [25]. They were selective in inhibiting ABCG2 (also known as breast cancer 
resistant protein, BCRP) and not the two other types of transporters (ABCB1 encoding P-glycoprotein, 
P-gp; or ABCC1 encoding multidrug associated protein 1, MDR-1) [26].  
Figure 1. Structures of some simple dehydro compounds.  
 
From the Mediterranean sponge, Hamigera hamigera, Hassan et al. [27] isolated two compounds 
called hamigeramine (15) and hamigeroxalamic acid (16) whose structures are shown in Figure 3. As 
is evident, they are simple dehydrotyramine derivates. Due to the low amount of the isolated materials, 
the  authors  could  not  perform  quantitative  studies,  but  qualitative  studies  reveal  that  these  two 
compounds, along with other unidentified compounds, exhibit fish feeding deterrent activity. Mar. Drugs 2010, 8  
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Figure 2. Structures of botryllamides. 
 
Figure 3. Structures hamigeramine and hemigeroxalamic acid.  
 
In 1996, Lindquist et al. isolated a group of dithiocarbamate related compounds from the marine 
hydroid, Tridentata marginata [28]. They named these compounds tridentatols A, B, and C (17, 18 and 
19). In addition, they also isolated a precursor molecule, tridentatol D (20), which did not possess any 
biological activity. The structures of these molecules are shown in Figure 4. Methylation of tridentatol 
D  (20)  could  give  rise  to  tridentatol  A  (17)  and  cyclization  of  tridentatol  D  (20)  will  generate 
tridentatol C (19). Tridentatol B (18) is the cis isomer of tridentatol A (17) that might be formed during 
the  dehydrogenation  reaction  of  a  precursor  molecule.  The  cis  isomer  exhibited  more  potent 
antioxidant  activity  against  LDL  oxidation  caused  by  copper  ions  than  the  naturally  occurring 
antioxidant Vitamin E in bioassays [29]. Moreover, these compounds also exhibited deterrent activity 
as well as protection against solar UV radiation damage [30]. Subsequently, Lindquist [31] isolated 
five more tridentatol derivates from the same organism and showed that four of them are sulfated 
derivatives of the tridentatols A–D (21–24). The sulfated compounds do not possess fish deterrent 
activity. Upon crushing the marine hydroid, the free forms that possess fish deterrent  activity are 
rapidly released [31]. Mar. Drugs 2010, 8  
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Figure 4. Structures of tridentatols (R = H, 17–20; R = OSO3Na are tridentatols E–H, 21–24). 
 
During  their  extended  series  of  studies  on  the  chemical  cues  that  alter  larval  settlement  and 
metamorphosis, Tsukamoto et al. [32] isolated new pipecolate derivatives called anthosamines A (25) 
and B (26) and a new diketopiperazine, cyclo-L-arginine-dehydrotyrosine (27), from a marine sponge 
that belong to the Clionidae class, Anthosigmella aff. raromicrosclera (Figure 5). These compounds 
possess  dehydrotyrosine  units  and  induce  larval  metamorphosis  in  ascidian  Halocynthia  roretzi. 
Anthosamine A (25) and B (26) exhibit  reversible isomerization between amine and iminium ion 
forms.  The  amine  form  predominately  occurs  in  the  aprotic  solvent  while  the  iminium  ion 
predominates in the protic solvents. The dehydrotyrosine group is conserved in the iminium form and 
is lost during conversion to the bicyclic amine form (Figure 5).  
Rigidin  A  (28,  Figure  6),  a  pyrrolepyrimidine  alkaloid  containing  a  dehydrotyramine  unit  was 
isolated from  the Okinawan marine tunicate,  Eudistoma cf. rigida [33]. This  compound  exhibited 
antagonistic activity against calmodulin. The biological activities of the related compounds, rigidin B 
(29), C (30) and D (31), which were isolated from a different species of tunicate, Cystodytes sp., are 
yet to be determined [34]. 
Figure 5. Structures of anthosamines (25, 26) and cyclo arginine dehydrotyrosine (27).  
 
Figure 6. Structures of Rigidins (28–31).  
 Mar. Drugs 2010, 8  
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3.  Simple  Dehydrodopa  Derivatives:  1,2-Dehydro-N-acetyldopamine,  Narain,  Jaspisin, 
Isojaspisin, Tubastrine, Orthidine and Wondonin A and B, Leucettamines  
1,2-Dehydro-N-acetyldopamine  (dehydro  NADA,  32)  is  one  of  the  most  thoroughly  studied 
dehydro compounds. Although this compound is of arthropod origin, given the fact that most of this 
review is devoted to dehydrodopa derivatives, and that a vast majority of marine metabolites possess 
the  basic  structure  of  this  compound,  it  is  important  to  discuss  the  biochemistry  of  this  novel 
compound. Andersen and his associates first isolated dehydro NADA (32) from the sclerotized cuticle 
of locusts and beetles [35,36]. Subsequently, Andersen and Roepstorff isolated this compound as a 
component of insect cuticle [37]. Since then its chemical synthesis, biogenesis, and potential biological 
reactions  via  oxidative  transformations  have  been  extensively  studied  by  one  of  our  research 
laboratories [38–45]. Although this simple compound is very widely used in insects as the major 
crosslinking agent to make protein-protein adducts, protein-chitin adducts and chitin-chitin adducts, 
during  cuticular  hardening  process,  it  is  also  known  to  possess  antioxidant  properties  [39].  This 
compound is very labile and easily undergoes both enzymatic and nonenzymatic oxidation forming 
dimers. Figure 7 for instance shows the phenoloxidase mediated dimerization of dehydro NADA. 
Several modifications of this simple structure are widely manifested in marine organisms, as we shall 
see later.  
Figure 7. 1,2-Dehydro-N-acetyldopamine and its dimer formation. Dehydro NADA (32) is 
oxidized by phenoloxidase to quinone methide imine amide (33) which adds on to the 
parent compound forming dimers via a transient intermediate. The reaction yields all four 
possible  stereoisomers  (34).  The  reaction  of  the  quinone  methide  imine  amide  with 
N-acetyldopamine will produce saturated dimers (35, not shown in the figure).  
 
The cast-off shell (exuviae) of the cicada of Cryptotympana sp. (Cicadidae) is used as a crude 
Chinese traditional medicine called ―Zentai‖, which is used as an antifebrile, a spasmolytic and as an 
antiphlogistic. It is also known to possess sedative and sympathetic ganglionic blocking activities. 
Since insect cuticle is mostly made of polymeric proteins and chitin and to lesser extent catecholamines, 
the suspected bioactive compound is most likely the catecholamine derivative. Accordingly, several 
groups of workers have isolated bioactive catecholamine compounds from insect cuticle.  Mar. Drugs 2010, 8  
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Noda et al. [46] first isolated a mixture of saturated dehydro NADA dimers (35) as the principle 
component of the drug. Following this work, Tada et al. [47] isolated the same compounds from a 
different  species  (Cryptotympana  tuslulata)  and  showed  that  they  possessed  strong  tyrosinase 
inhibitory  activity  and  could  be  used  as  potential  cosmetic  skin  whitening  agents.  Subsequently, 
Xu et al. [48] isolated both the saturated (35) and the unsaturated dimers (34) from the exuviae of 
cicadae available from their region. The unsaturated dimer (34) was far more effective in inhibiting 
reactive oxygen species (ROS) generation, inducible nitric oxide (NO) production and nuclear factor 
NF-kB activity in biological assays. This compound also induced pro-inflammatory molecules such as 
inducible  nitric  oxide  synthase  (iNOS),  interleukin  (IL)-6,  tumor  necrosis  factor  (TNF)-a  and 
cyclooxygnease (COX)-2 in lipopolysaccharide (LPS) induced cells [48]. Thus both the saturated and 
unsaturated  dimers  seem  to  possess  antioxidant  and  anti-inflammatory  properties.  However,  the 
―dehydrodopa‖ derivatives isolated from marine organisms possess even more interesting properties. 
The first compound to be identified in this group is tubastrine [49]. It is a guanido dihydroxystyrene 
compound (36) whose structure is shown in Figure 8. It was isolated from the bright orange-red coral, 
Tubastrea aurea in a polar extract, which also possessed antiviral activity against herpes simplex virus 
and vesicular stomatitis virus. Subsequently, Sperry and Crews [50] isolated this compound along with 
its saturated analog from the marine sponge, Petrosia cf. contignata. In a bioassay directed survey, 
Barenbrock and Kock [51] identified tubastrine (36) as the active compound from several ascidians 
that  showed  inhibition  of  epidermal  growth  factor  receptor  using  a  protein  tyrosine  kinase  assay. 
Tubastrine  was  isolated  as  the  principle  inhibitory  compound  from  the  ascidian, 
Dendrodoa grossularia [51]. Recently, Pearce et al. [52] identified tubastrine (36) and a number of its 
dimeric products called orthidines (37–41), from the ascidian, Aplidium orthium (Figure 8).  
Figure  8.  Structures  of  tubastrine  and  orthidines.  Orthidines  (37–41)  are  dimers  of 
tubastrine (36) formed by a similar mechanism shown in Figure 7 for the dimerization of 
dehydro NADA (32). 
 
The four benzodioxan dimers (orthidines A–D; 37–40) are the same kind that were characterized for 
dehydro NADA (32). The cyclobutane ring containing dimer (orthidine E, 41) is unique and has not 
been identified in any other system so far. Tubastrine (36) and its dimers (37–41) exhibited in vivo and Mar. Drugs 2010, 8  
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in vitro anti-inflammatory activities. These compounds drastically reduced the superoxide production 
by neutrophils in vivo in a murine model of gouty inflammation. Accordingly the in vitro production of 
superoxide  by  PMA-stimulated  human  neutrophils  was  inhibited  by  tubastrine  analogs  in  a  dose 
dependent fashion with an IC50 value ranging from 10–36 μM [52]. 
Jaspisin (42) was another dehydrodopa related compound that was isolated from the marine sponge, 
Jaspis sp. [53]. It is the sodium salt of (E)-5,6-dihydroxystyryl sulfate (Figure 9) and inhibited the 
fertilization of sea urchin gametes by blocking the exoplasmic membrane fusion with a minimum 
inhibition concentration of about 60 μM. The same authors also isolated and reported [54] the structure 
of the (Z) isomer, isojaspisin (43, Figure 9). Jaspisin (42) inhibited the fusion of acrosome reacted 
sperm with the plasma membrane of the egg [55]. However, it did not inhibit the acrosome reaction in 
sperm or the egg cortical reaction. It proved to be a powerful antihatching substance inhibiting the 
hatching enzyme from sea urchin, a zinc dependent metaloendoprotease [55].  
Figure 9. Structures of Jaspisin related compounds. 
 
Narains (E and Z isomers, 44, 45) are N,N-dimethylguanidium salts of dihydroxystyryl sulfates 
(Figure  9)  isolated  from  a  Jaspis  sp.  which  induce  larval  metamorphosis  in  the  ascidian 
Halocynthia roretzi [56]. Analogous to the dimers of dehydro NADA (32) and tubastrine (36), narains 
(and jaspisins) also form dimers (Figure 10). These dimers (46) also induce larval metamorphosis in 
ascidians Halocynthia roretzi and Ciona savignyi [57]. A slightly different dimer which has lost one 
sulfate unit was isolated from an association of the sponges, Poecillastra wondoensis and Jaspis sp., 
and named wondonins A and B (47, Figure 11). These compounds exhibited antiangiogenic activity 
against human umbilical vein endothelial cells [58]. 
Figure 10. Dimerization of jaspisin.  
 Mar. Drugs 2010, 8  
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Figure 11. Structure of wondonins.  
 
Three  new  imidazole  alkaloids  (48,  49  and  50)  were  isolated  from  a  Palauan  sponge, 
Leucetta microraphis [59]. Although leucettamine B (49) was inactive, leucettamine A (48, structure 
not shown), a compound possessing extra benzylic group, showed potent inhibition of leukotriene B4 
receptor binding activity with a Ki of 1.3 μM. In contrast, leucettamine C (50) exhibited only a mild 
antibiotic  activity  against  Eschericia  coli,  Staphylococcus  aureus,  Bacillus  subtilis  and 
Candida albicans [60]. Recently,  several  derivatives  of  leucettamine  B  (49)  were  synthesized  and 
shown to inhibit protein kinase activity [61]. Polyandrocarpamine A and B (51, 52), are related to 
leucettamines. They were isolated from a Fijian ascidian [62]. Polyandrocarpamine A (51) exhibits 
selective  cytotoxicity  against  central  nervous  system  cell  line  (SF  268)  with  a  GI  value  of  about 
65 μM [63]. The structures of these molecules are shown in Figure 12.  
Figure 12. Structures of polyandrocarpamines and leucettamines. 
 
4. Simple Peptidyl Dehydrotyrosine and Dehydrodopa Derivatives: Clionamide, Morulin PM, 
and Plicatamide  
The first peptide possessing a single dehydrodopa unit to be isolated from any organism was that of 
clionamide (53) extracted from the sponge Cliona celata [64]. It was shown to have the structure 
6-bromotryptophan-dehydrotopamine (53). It exhibited only a mild antibiotic activity in comparison 
with the potency of the crude Cliona extracts. Subsequent studies provided a number of additional 
peptidyl dehydrodopa compounds that may explain this discrepancy (discussed in the next two sections). 
Morulin PM (54) was isolated as an unusual post translationally modified peptide possessing both 
topa and 6-bromotryptophan residues from the morula cells of the vanadium accumulating ascidian, 
Phallusia mammillata by Taylor et al. [65]. Structural studies revealed that the C-terminal residue of 
the  peptide  possess  a  dehydrotopamine  residue.  Presence  of  both  dehydrotopamine  unit  and 
6-bromotryptophan  in  the  same  peptide  indicates  the  likelihood  of  antibacterial  activity  for  this Mar. Drugs 2010, 8  
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compound. However, test results have not supported this hypothesis so far, although more systematic 
studies  may  resolve  this  issue.  In  this  regard,  it  is  interesting  to  note  that  the  octapeptide  called 
plicatamide  (55),  possessing  the  structure  Phe-Phe-His-Leu-His-Phe-His-dehydrodopamine,  was 
isolated from the tunicate, Styela plicata, and shown to possess powerful antibiotic activity against 
Staphylococcus  aureus  [9,66]. Both  wild  type  and methicillin  resistant  S. aureus strains  exhibited 
massive  efflux  of  potassium  ions  upon  exposure  to  plicatamide.  Within  seconds  bacterial  strains 
exposed to plicatamide ceased to consume molecular oxygen and became nonviable. Plicatamide (55) 
was also shown to be a potent hemolytic agent against human erythrocytes but had no effect on ovine 
erythrocytes [66]. Its relatively small size, combined with the rapid impact on ion channels [66], make 
plicatamide a powerful lead compound to develop potential antibiotic compounds in future.  
While  not  a  member  of  the  peptidyl  dehydrotyrosine  and  dehydrodopa  derivatives  category  of 
compounds, styelins are a small group of dopa-containing peptides isolated from ascidians (Styela sp.) 
that exhibit antimicrobial activities against several kinds of bacteria and yeasts, and show cytotoxic 
activities against eukaryotic cells as well [67]. The hemocytes of Styela clava possess a 32 amino acid 
antimicrobial peptide, called styelin D, having multiple dopa units (but no dehydrodopa units) [8,67]. 
Styelin  D  inhibited  the  growth  of  both  Gram-positive  and  Gram-negative  bacteria  and  exhibited 
hemolytic and cytotoxic properties against eukaryotic cells. A much smaller tetra peptide possessing 
both dehydrotryptophan and dopa units, has been isolated and characterized from the hemocytes of the 
solitary ascidian, Halocynthia roretzi [10,68]. The remaining group of styelins (A, B, C and E), all 
isolated from  Styela  clava, form  pores  in  bacteria causing leaching of  nutrients  and eventual cell 
death [67]. Two other dopa- and topa-containing peptides, halocyamines [10] and ferreascidin [12], 
have also been isolated from tunicates.  
5. Peptides with Multiple Dehydrodopa Units: Tunichromes, Polyphenolic Protein and Celenamides  
Tunichromes were the first members of this group to be isolated. Tunichromes have been isolated 
solely from ascidians. They are small, modified peptides that have been extracted and characterized 
from blood cell lysates and tissues of the phlebobranch Ascidia nigra (An-1, An-2, An-3; 56, 57, 58) 
[13–16], the stolidobranch Molgula manhattensis (Mm-1, Mm-2; 59, 60) [16], and the phlebobranch 
Phallusia mammillata (Pm-1, Pm-2, Pm-3; 61, 62, 63) [17]. In addition, they have been identified by 
thin layer chromatography of hemocyte extracts in seven additional Phlebobranch species [18]. The 
structures  of  these  peptidyl  derivatives  are  presented  in  Figure  13  and  Table  1.  More  recently,  a 
modified  pentapeptide  tunichrome  (Sp-1;  64)  has  been  isolated  from  the  hemocytes  of  the 
stolidobranch ascidian Styela plicata [19].  
Common to all tunichromes is the presence of dehydrodopamine units. Many other peptides from 
tunicates, though not part of the tunichrome family of compounds, also possess dehydrodopamine units 
(for  structure,  refer  to  Table  1).  In  addition,  two  groups  of  peptides  isolated  from  the  sponge 
Cliona celata, the bromotryptophan containing dipeptide clionamide (53, discussed in section 4) [64] 
and  the  tri-  and  tetrapeptide  celenamides  (65–69)  [69–71],  most  of  which  contain 
dehydrodopamine/topamine units. Mar. Drugs 2010, 8  
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Figure 13. Structures of some tunichromes. 
 
Table 1. Structure of some tunichromes and related compounds.  
No.  Compound  Structure  References 
1  Tunichrome An-1, 56  Topa-DeTopa-DeTopamine  [14,15] 
2  Tunichrome An-2, 57  Dopa-DeTopa-DeTopamine  [14,15] 
3  Tunichrome An-3, 58  Dopa-DeTopa-DeDopamine  [14,15] 
4  Tunichrome Mm-1, 59  Gly-DeDopa-DeDopamine  [16] 
5  Tunichrome Mm-2, 60  Leu-DeDopa-DeDopamine  [16] 
6  Tunichrome Pm-1, 61  Topa-Topa-DeTopamine  [17] 
7  Tunichrome Pm-2, 62  Dopa-Topa-DeTopamine  [17] 
8  Tunichrome Pm-3, 63  Dopa-Topa-DeDopamine  [17] 
9  Tunichrome Sp-1, 64  Dopa-Dopa-Gly-Pro-DeDopamine  [19] 
10  Plicatamide, 55  Phe-Phe-His-Leu-His-Phe-His-DeDopamine  [9,66] 
11  Morulin Pm, 54  Polypeptide with 6-BrTrp & DeDopamine  [65] 
12  Clionamide, 53  6-BrTrp-DeTopamine  [64] 
13  Celenamide A, 65  Leu-DeTopa-6-BrTrp-DeDopamine  [69–71] 
14  Celenamide B, 66  Val-DeTopa-6-BrTrp-DeDopamine  [69–71] 
15  Celenamide C, 67  Leu-DeTopa-6-BrTrp-DeTyramine  [69–71] 
16  Celenamide D, 68  Leu-DeTopa-DeTopa-DeDopamine  [69–71] 
17  Celenamide E, 69  DeTopa-6-BrTrp-DeDopamine  [69–71] 
Several  antibacterial  peptides  including  styelins,  clavanins,  halocyamines  and  plicatamide  have 
been isolated from ascidians. Many of them possess dopyl units [8,10,66–68,72–76]. Due to extreme 
instability and low availability, tunichromes have not been generally tested for antibiotic properties. 
Preliminary  results,  using  a  novel  extraction  protocol  that  maintains  stability  of  the  native 
compounds [77], indicate that tunichrome mixtures isolated from Ascidia nigra, exhibit antimicrobial Mar. Drugs 2010, 8  
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activity  against  Gram-negative  bacteria  [78].  Future  studies  will  confirm  whether  this  antibiotic 
activity is widespread among the multiple dehydrodopa-containing peptides. 
Asidians  possessing  tunichromes  accumulate  large  amounts  of  trace  metals  such  as  vanadium 
and/or iron [16,79–81]. In Ascidia ahodori, vanadium comprised as much as 2% of the dry weight of 
the  hemocytes  [82].  It  was  originally  postulated  that  tunichromes  were  involved  in  metal 
accumulation [17,79–81]. However, this hypothesis is not in harmony with the finding that the metals 
are located in separate blood cells from the tunichromes [83]. Studies carried out in our laboratory 
suggest  that  tunichromes  are  associated  either  with  cross-linking,  wound  healing  and/or  tunic 
formation  [78].  In  this  regard,  it  is  important  to  point  out  that  the  monomeric  unit  found  in 
tunichromes,  namely  dehydrodopamine,  is  the  very  same  compound  that  is  involved  in  the 
sclerotization and hardening of insect cuticle [44,45]. During cuticular hardening in insects and most 
arthropods, structural proteins and carbohydrate polymer chitin are cross-linked and rendered insoluble 
by the covalent interaction with reactive intermediates generated from sclerotizing precursors such as 
N-acetyldopamine  and  N--alanyldopamine,  generally  called  N-acyldopamines  (70).  These  two 
precursors  are  enzymatically  converted  to  quinones  (71),  quinone  methides  (72)  and  dehydro 
N-acyldopamines  (73)  prior  to  cross-linking  [44,45].  Upon  enzymatic  oxidation,  dehydro 
N-acyldopamines (73) generate quinone methide imine amides (74) as initial two-electron oxidation 
products. These reactive intermediates then react non-enzymatically with chitin and protein to form 
protein-protein,  protein-chitin  and  chitin-chitin  adducts  and  cross-links  that  are  necessary  for 
hardening and gluing the cuticle. The course of sclerotization reactions employed by insects is depicted 
in Figure 14.  
Figure 14. Mechanism associated with the sclerotization of insect cuticle. 
 
Marine  bivalves  use  a  similar  multiple  dopyl-containing  protein  called  polyphenolic  protein 
(MW 130 kDa) under oxidative conditions to crosslink byssal threads in order to attach themselves and 
bind to solid surfaces [84–86]. Polyphenolic protein is composed of a decapeptide sequence containing 
a tyrosine and a dopa, which is repeated as many as 75 times [84]. With more than one dehydrodopa Mar. Drugs 2010, 8  
 
 
2919 
and/or dehydrodopamine units, tunichromes are likely to exhibit similar reactions, and hence may be 
involved in tunic formation and wound healing, which are similar to the processes involved in the 
hardening of insect cuticle [78].  
6.  Polycyclic  Condensed  Dehydrodopa  Derivatives:  Halitulin,  Storniamides,  Purpurones, 
Ningalins, Baculiferins, Lamellarin, Dictyodendrins, Polycitrins, Polycitones and Lukainols  
Kashman et al. [87], who have examined the chemistry and bioactivity of a number of  marine 
sponges, found that the extract of the sponge, Haliclona tulearensis (family Chalinidae) possessed 
cytotoxic activity and isolated an active component, which they named halitulin (75, Figure 15). This 
compound  exhibited  an  IC50  value  of:  (a)  25  μg/mL  against  P-388  murine  leukemia  cell  line; 
(b) 12 μg/mL against A-549 human lung carcinoma cells; (c) 12 μg/mL against HT-29 human colon 
carcinoma  cells;  and  (d)  25  μg/mL  against  MEL-28  human  melanoma  cell  line.  In  addition  to 
possessing  a  pyrrole  entity,  halitulin  also,  interestingly  enough,  possess  fused  dehydrodopamine 
units [87].  
Figure 15. Structure of halitulin. 
 
Marine  sponges  of  the  genus  Cliona  (family  Clionidae)  have  turned  out  to  be  rich  sources  of 
dehydrodopa containing compounds (see previous  discussions  in  Sections  4 and 5). Clionidae are 
burrowing organisms that live on calcareous substrates such as coral shells and rocks. They cause 
serious damage to coral beds and oyster reefs, since they can bore into calcareous structures easily. As 
mentioned earlier, clionamide (53, Section 4) and celenamides (65–69, Section 5) were two groups of 
compounds that were initially isolated from Cliona celata. Subsequently Palermo et al. [88] isolated 
storniamides  A–D  (76–79,  Figure  16)  through  a  bioassay  guided  fractionation  procedure,  and 
identified them to be a new group of pyrrole alkaloids exhibiting antibiotic activity against several 
Gram-positive bacteria. Bogar’s group [89] further studied these compounds and showed that they 
possess cytotoxicity against leukemia cell lines. In addition, they also identified multi drug resistance 
(MDR) reversal activity. Furstner et al. [90] also reported that storniamide A (76) possesses a DNA 
cleaving property, in addition to MDR reversal activity. Storniamides are probably biosynthesized by 
free radical coupling of the dipeptide, tyr-tyr followed by oxidative decarboxylation of the C-terminal 
carboxylic group. Dehydrotyrosyl-dehydrotyramine dimeric peptide thus formed, upon condensation 
with p-hydroxyphenylacetaldehyde (produced by monoamine oxidation of tyramine) will produce the 
basic stroniamide skeleton. 
A purple colored pentacylic dehydrodopa derivative called purpurone (80, Figure 17), was isolated 
from the Indopacific sponge of the genus Iotrochota, which was shown to inhibit ATP citrate lyase Mar. Drugs 2010, 8  
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activity with an IC50 value of 25 mg/mL [91]. ATP citrate lyase is essential for the synthesis of acetyl 
CoA and hence reduction in the production of acetyl CoA could drastically affect both lipogenesis and 
choleterogenesis.  Therefore,  purpurone  (80)  could  be  a  valuable  drug  to  lower  low-density 
lipoproteins, which are produced from fatty acid and cholesterol. Since purpurone was liberated by 
acid hydrolysis, it is probably present as a sugar and/or protein conjugate. Purpurone (80) has also 
been isolated from a south sea marine sponge of the same genus, Iotrochota, by a bioactivity-guided 
protocol aimed at identifying antioxidant compounds by Liu et al. [92].  
Figure 16. Structures of Storniamides. 
 
A  hydroxylated  derivative  of  purpurone  was  subsequently  isolated  from  a  western  Australian 
unidentified ascidian belonging to the genus Didemnum and named ningalin D (81) [93]. These authors 
also isolated a number of biogenetically related compounds that were like purpurone from the same 
organism (ningalins  A, B, and C; 82–84, Figure 17). Both  ningalins, as  well as  their derivatives, 
exhibited  marked  cytotoxicity  against  several  cancer  cell  lines.  In  addition,  they  also  exhibited 
significant MDR reversal activity at non-cytotoxic concentrations [94,95]. Recently a group of about 
five  different  compounds  that  are  derivatives  of  purpurone  and  ningalins  were  isolated  from  the 
Chinese marine sponge, Iotrochota baculifera and shown to possess anti HIV-1 activity [96]. Since 
ningalins  resemble  a  number  of  lamellarins,  it  was  proposed  that  ningalins  might  serve  as  the 
biosynthetic precursor for a number of lamellarins [93]. 
Figure 17. Structures of purpurone and ningalins. 
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Lamellarins are a group of over seventy different polycyclic condensed aromatic compounds [11]. 
Faulker and his group first reported the isolation and characterization of four lamellarins from the 
prosobranch mollusc, Lamellaria sp. in 1985 and named them lamellarin A–D [97]. Subsequently, four 
additional  members  of  this  group  (E–H)  were  isolated  form  the  didemnid  ascidian 
Didemnum chartaceum [98]. Since then, as many as seventy different, yet structurally closely related, 
polycyclic  aromatic  condensed  compounds  have  been  isolated  from  a  variety  of  marine  organism 
possessing a wide range of biological activities that include (yet not limited to) cytotoxicity, antibiotic 
activity,  antitumor  activity,  antioxidant  activity,  MDR  reversal  activity,  HIV  integrase  inhibition, 
human aldose reductase inhibition, cell division inhibition, immunomodulatory activity, and feeding 
deterrent activity [11]. Since an excellent review article is available solely on all lamellarins [11], it is 
unnecessary to review the structure function aspect of lamellarins again here. Lamellarins fall broadly 
under three structural categories shown in Figure 18. The majority of the lamellarins possess either 
Type 1a or 1b structures  (85,  86). These  compounds  contain the dehydrodopamine unit. The  last 
structure  (i.e.,  unfused  lamellarins,  87)  lacks  the  dehydrodopamine  unit  but  possesses  instead 
dehydrotyramine unit. Only a few compounds (about four) belong to this category. Interestingly, a 
number of related compounds possessing only dehydrotyramine units are also identified from marine 
organisms  and  the  rest  of  this  section  deals  with  such  compounds.  Even  though  they  are  not 
dehydrodopamine containing molecules, since they are all polycyclic condensed molecules similar to 
lamellarins, they are listed here for simplicity’s sake.  
Figure 18. Structures of lamellarins.  
 
Warabi et al. [99] isolated five compounds, which they named dictyodendrins (A–E; 88–92), from 
the sponge Dictyodendrilla verongiformis, as potent inhibitors of telomerase. Structures of some of 
these  compounds  along  with  two  related  compounds  (93,  94)  [100]  are  shown  in  Figure  19. 
Telomerase, which adds repeats of TTAGGG units called telomeres, to the 3’-end of chromosomes, is 
inhibited by these compounds at 50 μg/mL level. Since telomerase is found nearly in 90% of cancer 
cells  but  not  in  any  significant  amount  in  normal  cells,  this  finding  could  pave  the  way  to  the 
development of new kinds of anticancer drugs.  Mar. Drugs 2010, 8  
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Rudi et al. [101] isolated polycitrin A (95) and polycitone A (96) (Figure 20) from the ascidian, 
Polycitor sp. in 1994 and showed that the penta-O-methyl derivative of polycitone A (96) could inhibit 
SV40 transformed fibroblast cells at concentrations as low as 10 μg/mL. Subsequently, this group was 
able  to  demonstrate  the  inhibition  of  retroviral  reverse  transcriptases  (isolated  from  human 
immunodeficiency virus, murine leukemia virus, and mouse mammary tumor virus) as well as cellular 
DNA polymerase (DNA polymerase B and E. coli DNA polymerase I) activities by polycitone A (96) 
[102].  Furthermore,  they  also  isolated  polycitone  B  (97)  and  prepolycitrin  A  from  the  ascidian, 
Polycitor africanus [103].  
Figure 19. Structures of dictyodendrins.  
 
Figure 20. Structure of polycitrin A (95) and polycitones (96, 97).  
 
From the extracts of a Pacific tunicate, Scheuer et al. [104] isolated lukianol A and B (98, 99; 
Figure 21). Both compounds exhibited toxicity against a human epidermatoid carcinoma cell line. 
Lukianol  A  (98)  possessed  a  minimum  inhibitory  concentration  of  1  μg/mL  and  lukianol  B  (99) 
possessed  a  minimum  inhibitory  concentration  of  100  μg/mL.  Subsequently,  Boger  et  al.  [89] Mar. Drugs 2010, 8  
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synthesized and tested lukianol A (98) and other related synthetic compounds on a group of cancer cell 
lines.  The  results  indicated  that  these  compounds  possessed  IC50  values  ranging  from  1–20  μM. 
Although lukianol A did not possess any MDR reversal activity on the cellular P-glycoprotein efflux 
pump, one of its synthetic precursors showed a reasonable MDR reversal activity at non-cytotoxic 
concentrations. In this regard, it is interesting to note that the pyrroles possessing phenolic substituents 
seem to be associated with cytotoxicity, whereas phenolic ethers tend to exhibit MDR reversal activity. 
Gupton’s  group  [105,106]  synthesized  one  of  the  key  intermediate  of  lukianol  A  (98)  and 
demonstrated its potent cytotoxicity against a number of cancer cell lines with ED50 values ranging 
from of 3–20 μM. In the lymphocytic leukemia cell lines, this compound also inhibited both DNA 
synthesis and protein synthesis by inhibiting a number of key enzymes such as DNA polymerase a, 
some  RNA  polymerases,  ribonucleotide  reductase,  dihydrofolate  reductase,  phosphoribosyl 
pyrophosphate transferase and IMP dehydrogenase [105,106]. Even compounds with only one aryl 
group showed cytotoxicity at the same level as the diaryl pyrrole [105,106]. 
Figure 21. Structure of lukianols.  
 
7. Biogenesis of Dehydro Compounds 
From the foregoing discussion it is evident that unusually large numbers of dehydrotyrosine and 
dehydrodopa compounds are biosynthesized in marine organisms. In spite of accumulation of such a 
vast knowledge on the isolation and characterization of a plethora of these molecules, the information 
on  their  biosynthetic  pathways  is  pretty  scarce.  Therefore,  one  can  only  hypothesize  on  their 
biosynthetic mechanism(s), based on what little is known about the biosynthesis of dehydrotyrosine 
and dehydrodopa compounds. From the structures, it is evident that these compounds arise by the 
introduction of the double bond in the side chain of the saturated derivatives of the parent compounds 
viz., tyrosine and dopa. Examination of the biosynthetic literature on the fate of tyrosine and dopa 
reveals that two different routes make dehydrotyrosine and dehydrodopa derivatives. The introduction 
of the double bond in peptidyl tyrosine units can be achieved by the action of the recently identified 
enzyme, tyrosine side chain oxidase [107]. This enzyme, first identified in the biosynthesis of the 
antibiotic  compound,  chondrochloren  (100,  101)  produced  by  Chondromyces  crocatus,  causes 
oxidative  decarboxylation  of  an  acyltyrosine  peptide  (102)  (synthesized  by  nonribosomal  peptide 
synthesis) to a dehydrotyramine containing compound (Figure 22).  Mar. Drugs 2010, 8  
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Figure 22. Formation of dehydrotyramine. 
 
Isolation and expression of the gene in E. coli and examining the gene product revealed that it is a 
FAD-dependent  oxidative  decarboxylase  [107].  It  seems  to  oxidize  tyrosine  precursor  (102)  to  a 
transient quinone methide (103) by extracting two hydrogen atoms from the 1,6 position (from the 
phenolic group and the methylene group, as shown in Figure 22). The resultant quinone methide (103) 
spontaneously loses the carboxyl group and undergoes isomerization to a dehydrotyramine-containing 
compound (100, 101). If the carboxyl group is blocked by acylation, such as peptide bond formation, 
the carboxyl group will remain intact. Loss of a proton from the neighboring methylene group in such 
molecules and simultaneous aromatization of the quinone methide nucleus, results in the generation of 
dehydrotyrosine units. On the other hand, if the carboxyl group is unprotected, it will suffer a rapid and 
spontaneous nonenzymatic decarboxylation reaction accompanied by the aromatization of the quinone 
methide  nucleus  that  generates  dehydrotyramines.  A  direct  hydroxylation  of  dehydrotyrosines  and 
dehydrotyramines  by  a  tyrosinase  type  enzyme  can  lead  to  the  dehydro  derivatives  of  dopa  and 
dopamine. Alternatively, dehydrodopa and dehydrodopamines can also be made from their saturated 
analogs by a different route. The amino acid tyrosine is converted to dopa in a number of biological 
systems by the action of a specific tyrosine  hydroxylase as well as by tyrosinase. While tyrosine 
hydroxylase reaction stops at the production of dopa, the tyrosinase acts further on the resultant dopa 
generating dopaquinone as the transient two-electron oxidant product. Dopaquinone is highly unstable 
and undergoes rapid intramolecular cyclization producing leucochrome initially, which gets further 
oxidized nonenzymatically to produce a series of compounds that finally result in the polymerization 
and production of melanin pigments [44,45,108]. This reaction, which is useful for the biosynthesis of 
melanin  polymer,  is  not  very  helpful  for  producing  dehydro  derivatives  of  dopa  and  dopamine. 
Protecting  the  amino  group  by  acylation  deactivates  the  amino  group  reactivity  and  prevents  the 
intramolecular cyclization of protected dopaquinones. Such compounds, upon oxidation by tyrosinase, 
can generate dehydrodopa derivatives. For instance, the deaminated dopa, dihydrocaffeic acid (104), Mar. Drugs 2010, 8  
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upon oxidation by tyrosinase produces both dihydroesculetin (105, a cyclized product) and traces of 
caffeic acid (desaturated product) as shown in Figure 23 [109]. If the carboxyl group is also prevented 
from exhibiting intramolecular cyclization reaction—say by amide formation or esterification—the 
resultant dihydrocaffeate derivates (106) solely exhibit side chain desaturation reaction when oxidized 
by  tyrosinase  [109,110].  The  reaction  was  shown  to  occur  by  the  spontaneous  isomerization  of 
tyrosinase produced quinone (107) to  quinone methide (108) and subsequent  aromatization  of the 
quinone methide with the introduction of the double bond in the side chain leading to the caffeic acid 
derivatives (109) (Figure 23).  
Figure  23.  Oxidative  transformation  of  protected  dopa  compounds.  Deaminated  dopa 
(dihydrocaffeic  acid),  upon  oxidation  to  quinone,  undergoes  intramolecular  cyclization, 
producing  a  dihydroesculetin  type  structure  that  is  prevalent  in  lamellarins  and  other 
compounds (top line). If the carboxyl group is protected, the resultant quinone undergoes 
isomerization to quinone methide and then produces dehydro compounds (middle line). 
The same reaction is also exhibited by N-acyldopa esters, as shown on the last line. 
 
Dopa derivatives also exhibit this reaction when both the carboxyl and amino groups are protected 
by  acylation  and  amide  formation.  Accordingly,  the  tyrosinase  generated  quinones  from  both 
N-acetyldopa methyl ester and ethyl esters (110) exhibit spontaneous isomerization reaction to produce 
dehydrodopa derivatives (113) via quinone (111) and quinone methide intermediates (112) [111,112]. 
Thus peptidyl dopa derivatives can be converted to dehydro dopa units by simple tyrosinases that are 
present ubiquitously in biological systems without the need for any other enzymes. On the other hand, 
if the carboxyl (or carbonyl) group is absent to assist the quinone-to-quinone methide conversion, as in 
the  case  of  1,2-dehydro-N-acyldopamine  production,  there  is  a  need  for  additional  enzymatic 
catalysts [113–115]. If the carboxyl group in dopa is decarboxylated to dopamine, direct introduction 
of the double bond into its side chain is rather difficult. However, this reaction is achieved by the use 
of  tyrosinase  and  quinone  isomerases  [44,45].  Unprotected  simple  dopamine  will  generate  only 
melanin  type  molecules  as  mentioned  earlier.  But  if  the  amino  group  is  protected  by  acylation, 
N-acyldopamines thus formed, upon oxidation by tyrosine will produce N-acyldopamine quinones that 
are  quite  stable.  We  have  identified  two  separate  isomerases—one  that  acts  on  N-acyldopamine 
quinone producing quinone methide [113,114] and the other,  which acts  on the resultant  quinone Mar. Drugs 2010, 8  
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methide producing the side chain desaturated product—dehydrodopamine [115]. Thus if the carboxyl 
group is removed from dopa, one has to have two additional enzymes to cause the isomerization of the 
quinone and the quinone methide (shown in Figure 14). Finally, dehydrodopamine can also arise from 
the  decarboxylation  of  amino  protected  dopaquinone  derivatives  after  quinone  methide  formation, 
much like the tyrosyl peptide to dehydrotyramine peptide route discussed above. 
Examination of the structures of a number of condensed compounds indicates that coumarin type 
molecules are also formed routinely in ningalins and lamellarins. This  condensation can occur by 
intramolecular cyclization of N-protected dopyl compounds to form the six-membered ring [109]. We 
have shown such a facile cyclization as early as 1989 in the case of dihydrocaffeic acid (Figure 23 top 
line). Finally, enzymology of the biosynthetic process of all these naturally occurring compounds is 
practically untouched and might yield rich details for future investigators. All our attempts to identify 
the isomerases in ascidians have so far fallen short of confirming their presence in tunicates. More 
biochemical studies are necessary to throw light on this process. 
8. Conclusions  
Dehydrotyrosyl  and  dehydrodopyl  compounds  have  been  isolated  from  a  broad  range  of 
invertebrate phyla (Table 2). These compounds are generally either peptides or small proteins. All 
have been isolated from organisms that are sedentary as adults. Furthermore, each of these compounds 
is  bioactive  to  some  degree,  most  likely  due  to  the  highly  reactive  catechol  group(s).  However, 
different types of bioactivity have been reported for different compounds, including antibiotic and 
other  defense  activities,  enzyme  inhibition,  free  radical  mediation,  wound  repair,  and  structural 
crosslinking of components of exoskeletons. All of these varied processes can be, in theory, attributed 
to  reactive  catechols.  Surprisingly,  these  diverse  compounds  appear  quite  common  in  two  widely 
separated Phyla—the simple metazoan sponges (Phylum Porifera) and, at the opposite extreme, the 
bilateral eumetazoan deuterostome ascidians (Phylum Chordata, subphylum Urochordata). Examples 
have also been isolated from intermediate phyla, including the radially symmetrical Phylum Cnidaria 
(hydroids), and the bilateral protostome Phylum Mollusca (bivalves). Even more surprising, several of 
the same dopa-containing compounds have been isolated from members of different phyla (Table 2). 
The simple dehydrodopa compound tubastrine has been found in  a sponge, a coelenterate and an 
ascidian. In the ascidian, not only has the monomeric tubastrine (36) been identified, but a dimeric 
form (named orthidine, 37–41) has also been isolated. In addition, the tri-peptide tunichromes, which 
are widespread in the ascidians, are structurally similar to the bromotryptophan-containing dipeptide 
clionamide (53) and to the tri- and tetra-peptide celenamides (65–69), both of which are found in 
sponges. Finally, the more complex, polycyclic condensed dehydrodopa compound purpurone (80) 
was  originally  isolated  from  a  sponge,  but  has  also  turned  up  in  an  ascidian  as  a  hydroxylated 
derivative, ningalin D (81). A second polycyclic dehydrodopa family, the lamellarins, was isolated 
from both a snail and an ascidian. 
Given  this  widespread  distribution  of  dehydrotyrosyl  and  dehydrodopyl  compounds  among  the 
invertebrate phyla, and the discovery of the same compounds in widely separate phyla, it appears that 
the ability to synthesize this group of compounds arose very early in evolutionary history, and has been 
retained by a variety of animals because of its selective advantage. It is also possible that bacterial Mar. Drugs 2010, 8  
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symbionts  could  form  a  potential  source  of  these  compounds.  It  is  likely  that  examples  of  these 
compounds have been found in sponges, hydroids, bivalves and ascidians simply because scientists 
happened to have looked for them in these groups. If this is the case, then it is very likely that similar 
compounds are present in other phyla that have yet to be examined. Since all of the organisms that 
have been successfully assayed to date are sedentary organism, the search for additional compounds 
should  probably  begin  with  members  of  the  fouling  communities,  including  additional  hydroids, 
sedentary polychaete worms, barnacles, bryozoans, and ectoprocts. In addition, one major phylum that 
has yet to be tested is the ecdhinoderms (seastars, brittle stars, sea urchins, sea cucumbers, etc.).  
Table 2. Dehydrotyrosyl and dehydrodopyl compounds found in various groups of marine 
invertebrates. The five categories are explained in the text. The same compound isolated 
from different groups of animals is highlighted in red. 
Category  Sponges  Coelenterates  Molluscs  Ascidians 
1  Hamigeramine (15); Hamigeroxalamic 
acid (16);  
Anthosamine A & B (25, 26);  
Cyclo-L-arginine-dehydrotyrosine (27) 
Tridentatols A–D 
(17–20) 
  Botryllamide (5–14); Rigidin 
A–D (28–31) 
2  Tubastrine (36);  
Jaspisin (42);  
Isojaspisin (43);  
Narains (44, 45);  
Wondonins (47);  
Leucettamine A–C (48–50) 
Tubastrine (36)    Tubastrine (36);  
Orthidines (37–41);  
Polyandrocarpamine A & B 
(51, 52) 
3  Clionamide (53)      Morulin PM (54);  
Plicatamide (55);  
Styelin A–D 
4  Celenamides (65–69)    Polyphenolic 
protein 
Tunichromes (56–64) 
5  Purpurone (80);  
Halitulin (75);  
Storniamide A–D (76–79);  
Dictyodendrin A–E (88–92) 
  Lamellarin 
A–D 
Ningalin D (81);  
Ningalin A–C (82–84);  
Lamellarin E–H;  
Polycitrin A (95);  
Polycitone A & B (96, 97);  
Lukianol A & B (98, 99) 
A careful ―deconstruction‖ of all the compounds mentioned in this review indicates that they all 
start the same way, perhaps from peptidyltyrosine and/or peptidyldopa units. They are most likely 
synthesized primarily by two different routes. The first involves post-translational modification of 
simple  peptides  obtained  by  traditional  ribosomal  synthesis.  The  second  employs  nonribosomal 
peptidyl  assembly followed by post-translational  modification of the resultant  small peptide. Both 
routes are likely to function. Additional post-translational modifications are necessary to produce the 
final compounds in many cases. Neither the mechanisms nor the sites of synthesis of these compounds 
have yet been explored.  Mar. Drugs 2010, 8  
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As a final note, compiling the list of compounds we have reported on in this review (e.g., Table 2) 
was not a trivial task, given the morass of common names published in the literature. Nomenclature 
was not based on structural attributes (e.g., tyrosyl or dopyl based), making literature searches difficult. 
We  could  very  easily  have  missed  additional  related  compounds  in  our  searches.  We  highly 
recommend that authors carefully consider structurally based nomenclature and use structurally based 
key words (e.g., dehydrotyrosine, dehydrodopa, etc.) when publishing newly discovered natural products.  
We  have  reviewed  the  widespread  occurrence  of  dehydrotyrosyl  and  dehydrodopyl  containing 
compounds in marine invertebrate phyla, and have highlighted the structural similarities among them. 
Furthermore, we have speculated that all of these compounds originate via common pathways. Now 
that  we  better  understand  the  interrelationships  among  these  compounds,  more  in-depth  structural 
comparisons  relative  to  a  specific  type  of  bioactivity  is  now  possible.  For  example,  all  of  these 
structures should be compared in the context of antimicrobial activity. This will allow us to suggest 
structural modifications (reactive and nonreactive side groups, hydroxylations, methylations, etc.) that 
could be used to optimize antimicrobial activity. These suggested changes can be tested following 
synthesis of model compounds in the laboratory. At the same time, we should not avoid a further 
search for new lead dehydrotyrosyl and dehydrodopyl compounds in additional species of sponges, 
coelenterates,  molluscs  and  ascidians,  as  well  as  in  other  marine  phyla  that  have  so  far  been 
overlooked.  This  will  provide  us  with  additional  structures  to  include  in  our  scheme  of  possible 
structural similarities.  
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